Dated disclosed rounds · latest 2025-05-08
Other / review
OrganOx
Medical devices — normothermic organ (liver) perfusion technology
- Companies House
- 06557113
- GLEIF LEI
- Not matched
- Latest evidence
- 2025-05-08
- Evidence snapshot
- 2026-08-25
Exact award notices · latest No exact award match
2026-08-25T03:23:50.893Z
Jun 2026
Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.
Evidence timeline
10 dated observations
Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.
RegistryRecord observation Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
FundingSource fact Equity financing, 2nd private-placement closing (same program as above, incremental new money — not a fresh priced round)
~$18M incremental (brought the financing program's cumulative total to $160M) · 1 named investor
FundingSource fact Equity financing, 1st closing
$142M · 2 named investors
FundingSource fact Growth round (aggregators label this 'Series D')
£25M (reported as $32.6-32.7M) · 2 named investors
FundingSource fact BGF follow-on
£4.6M (~$5.36M) · 1 named investor
FundingSource fact BGF first investment (label uncertain — inferred later 'Series C'-equivalent by sequence)
undisclosed · 1 named investor
FundingSource fact Follow-on round (label uncertain — inferred later 'Series B'-equivalent by sequence, not an explicit company label)
just under £1 million (imprecise per source) · 2 named investors
RegistryRegistry fact Company incorporated
ORGANOX LIMITED · company 06557113
FundingSource fact Seed / proof-of-concept
£250,000 · 1 named investor
FundingSource fact Early round (Oxford University Innovation calls it 'seed'; one outlet's headline calls it 'Series A')
£1.5M · 2 named investors
Latest disclosed round
Equity financing, 2nd private-placement closing (same program as above, incremental new money — not a fresh priced round)
- Date
- 2025-05-08
- Amount
- USD 18m
- Sector
- Healthtech & digital health; Deeptech / hardware
- Companies House
- 06557113
- ONS region
- South East
Evidence status
Directory ready
- Identity
- Verified
- Match
- High — exact company number and aligned registered name
- Operating status
- active
- Data origins
- Core directory, Live Chris T D1
Capital network
11 linked investors
Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.
| Investor | Role | Date | Source | Match / state |
|---|---|---|---|---|
| BGF | lead | 2020-01-08 | Bgf ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| HealthQuest Capital (new) | lead | 2025-02-24 | Globenewswire ↗ · Lw ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Lauxera Capital Partners | lead | 2023-07-17 | Globenewswire ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Longwall Venture Partners (continuing | lead | 2013-2014 | VC research snapshot; Live Chris T D1 · no retained URL | reviewed canonical company and investor alias resolutionsource-linked · published |
| no lead explicitly named) | lead | 2013-2014 | VC research snapshot; Live Chris T D1 · no retained URL | reviewed canonical company and investor alias resolutionsource-linked · published |
| Oxford Technology Management Ltd (later Longwall Ventures) | lead | 2008 | Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Technikos | lead | 2008 | Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| University Challenge Seed Fund | lead | 2008 | Ac ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Existing investors (not individually named in the release) | participant | 2023-07-17 | Globenewswire ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Existing: BGF (£20M of this round specifically), Lauxera Capital Partners, University of Oxford, Technikos, Oxford Technology and Innovations Fund, Longwall Ventures. New: Sofina, Soleus Capital, Avidity Partners | participant | 2025-02-24 | Globenewswire ↗ · Lw ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| New: Intuitive Ventures, Terumo Ventures, Piper Heartland Healthcare LLC | participant | 2025-05-08 | Globenewswire ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Funding record
8 disclosed rounds
Open a dated round to move directly between the company, named investors and source publication.
| Date | Stage | Amount | Investors | Named sources |
|---|---|---|---|---|
| 2025-05-08 | Equity financing, 2nd private-placement closing (same program as above, incremental new money — not a fresh priced round) | ~$18M incremental (brought the financing program's cumulative total to $160M) | New: Intuitive Ventures, Terumo Ventures, Piper Heartland Healthcare LLC | Globenewswire ↗ |
| 2025-02-24 | Equity financing, 1st closing | $142M | HealthQuest Capital (new) · Existing: BGF (£20M of this round specifically), Lauxera Capital Partners, University of Oxford, Technikos, Oxford Technology and Innovations Fund, Longwall Ventures. New: Sofina, Soleus Capital, Avidity Partners | Globenewswire ↗ · Lw ↗ |
| 2023-07-17 | Growth round (aggregators label this 'Series D') | £25M (reported as $32.6-32.7M) | Lauxera Capital Partners · Existing investors (not individually named in the release) | Globenewswire ↗ |
| 2020-01-08 | BGF follow-on | £4.6M (~$5.36M) | BGF | — |
| 2019 | BGF first investment (label uncertain — inferred later 'Series C'-equivalent by sequence) | undisclosed | BGF | Bgf ↗ |
| 2013-2014 | Follow-on round (label uncertain — inferred later 'Series B'-equivalent by sequence, not an explicit company label) | just under £1 million (imprecise per source) | Longwall Venture Partners (continuing · no lead explicitly named) | — |
| 2008 | Seed / proof-of-concept | £250,000 | University Challenge Seed Fund | Ac ↗ |
| 2008 | Early round (Oxford University Innovation calls it 'seed'; one outlet's headline calls it 'Series A') | £1.5M | Technikos · Oxford Technology Management Ltd (later Longwall Ventures) | Ac ↗ |
Companies House status and filing snapshot
ORGANOX LIMITED
Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.
Registered record
- Status
- Active
- Company type
- Private Limited Company
- Country of origin
- United Kingdom
- Incorporated
- 2008-04-07
- Dissolved
- Not applicable
- Company number
- 06557113
Filing context
- Accounts category
- GROUP
- Accounts made up to
- 2024-12-31
- Next accounts due
- 2026-12-31
- Confirmation made up to
- 2026-04-07
- Registry snapshot
- 2026-08-01
- Live check
- 2026-08-25T03:23:50.893Z
CompanyBeacon statutory projection
ORGANOX LIMITED
UK Capital Intelligence owns the capital view on this page. CompanyBeacon owns the exact legal-entity, filing, control and public-record timeline for company number 06557113.
Latest retained status
active
- Checked
- 2026-08-25T03:23:50.893Z
- Recorded change
- No change timestamp retained
- Previous status
- active
- Fund associations
- 1 dated CompanyBeacon membership
Boundary
Verify the legal record
Fund association does not prove a current holding. Status change is a review signal, not investment performance or wrongdoing. Ownership and control are not copied into this public UKCI package.
Open CompanyBeacon record ↗Traceability
Source trail
Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.